Novo Nordisk presents findings of obesity care study
5 November 2015 | By Victoria White
Results from the study highlight a general lack of understanding of obesity as a disease and its impact on the body...
List view / Grid view
5 November 2015 | By Victoria White
Results from the study highlight a general lack of understanding of obesity as a disease and its impact on the body...
5 November 2015 | By Victoria White
The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778...
5 November 2015 | By Victoria White
Sanofi and Hanmi have entered a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments...
5 November 2015 | By Victoria White
GlobalData says this rise will be driven primarily by the introduction of novel drugs, most notably Shire’s lifitegrast, a first-in-class drug with anti-inflammatory benefits...
4 November 2015 | By Victoria White
Saxenda in combination with reduced-calorie diet and increased physical activity also delayed the onset of type 2 diabetes in the three-year extension trial...
4 November 2015 | By Victoria White
Janssen-Cilag International has submitted a Type II variation application to the European Medicines Agency (EMA), which seeks to broaden the existing marketing authorisation for Imbruvica (ibrutinib) to include previously untreated patients with chronic lymphocytic leukaemia (CLL).
4 November 2015 | By New England BioLabs, Inc.
New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems...
4 November 2015 | By Victoria White
Avelumab is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody that potentially uses the body’s own immune system to fight cancer...
4 November 2015 | By Victoria White
Scientists have shown that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment...
4 November 2015 | By Victoria White
Tavilermide is differentiated from other investigational therapies in dry eye disease because it induces the production of mucin...
4 November 2015 | By Victoria White
ESCMID believes that one vital tool to increase the adoption of flu vaccinations among healthcare professionals is to establish hospital-based league tables throughout Europe...
4 November 2015 | By Victoria White
Ikervis has been recommended for the treatment of keratitis in adults with dry eye disease who have not responded to tear substitutes...
4 November 2015 | By Victoria White
From June 2016, medicines for the treatment of dementia will include the days of the week clearly on the blister packs...
3 November 2015 | By London Business School
The Future of Healthcare - striking a balance between patients, value and innovation. Monday 7 December 2015...
3 November 2015 | By Victoria White
Results from the study show that cabotegravir and rilpivirine were comparable in maintaining viral suppression rates to a three drug oral regimen...